BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26849074)

  • 1. The Immunomodulatory Potential of Mesenchymal Stromal Cells: A Story of a Regulatory Network.
    Najar M; Raicevic G; Crompot E; Fayyad-Kazan H; Bron D; Toungouz M; Lagneaux L
    J Immunother; 2016; 39(2):45-59. PubMed ID: 26849074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells.
    Najar M; Raicevic G; Fayyad-Kazan H; Bron D; Toungouz M; Lagneaux L
    Cytotherapy; 2016 Feb; 18(2):160-71. PubMed ID: 26794710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunomodulatory properties of human bone marrow-derived mesenchymal stromal cells are defined according to multiple immunobiological criteria.
    Fayyad-Kazan H; Faour WH; Badran B; Lagneaux L; Najar M
    Inflamm Res; 2016 Jun; 65(6):501-10. PubMed ID: 26956767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stromal Cell Therapy in MDR/XDR Tuberculosis: A Concise Review.
    Joshi L; Chelluri LK; Gaddam S
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):427-33. PubMed ID: 26100384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of mesenchymal stromal cell immunomodulation.
    English K
    Immunol Cell Biol; 2013 Jan; 91(1):19-26. PubMed ID: 23090487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characteristics and immunoregulatory functions of regulatory dendritic cells induced by mesenchymal stem cells derived from bone marrow of patient with chronic myeloid leukaemia.
    Zhao ZG; Xu W; Sun L; Li WM; Li QB; Zou P
    Eur J Cancer; 2012 Aug; 48(12):1884-95. PubMed ID: 22129888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes.
    Saldanha-Araujo F; Ferreira FI; Palma PV; Araujo AG; Queiroz RH; Covas DT; Zago MA; Panepucci RA
    Stem Cell Res; 2011 Jul; 7(1):66-74. PubMed ID: 21546330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunomodulatory function of mesenchymal stem cells: mode of action and pathways.
    Uccelli A; de Rosbo NK
    Ann N Y Acad Sci; 2015 Sep; 1351():114-26. PubMed ID: 26152292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects.
    Fontaine MJ; Shih H; Schäfer R; Pittenger MF
    Transfus Med Rev; 2016 Jan; 30(1):37-43. PubMed ID: 26689863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
    Zimmermann JA; McDevitt TC
    Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are mesenchymal stromal cells immune cells?
    Hoogduijn MJ
    Arthritis Res Ther; 2015 Mar; 17(1):88. PubMed ID: 25880839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms.
    Nasef A; Ashammakhi N; Fouillard L
    Regen Med; 2008 Jul; 3(4):531-46. PubMed ID: 18588475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming immunoregulatory plasticity of mesenchymal stem cells for accelerated clinical applications.
    Kim N; Cho SG
    Int J Hematol; 2016 Feb; 103(2):129-37. PubMed ID: 26662288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory effects on T lymphocytes by human mesenchymal stromal cells isolated from bone marrow, amniotic fluid, and placenta.
    Mareschi K; Castiglia S; Sanavio F; Rustichelli D; Muraro M; Defedele D; Bergallo M; Fagioli F
    Exp Hematol; 2016 Feb; 44(2):138-150.e1. PubMed ID: 26577566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory perspective on in vitro potency assays for human mesenchymal stromal cells used in immunotherapy.
    de Wolf C; van de Bovenkamp M; Hoefnagel M
    Cytotherapy; 2017 Jul; 19(7):784-797. PubMed ID: 28457740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
    Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of mesenchymal stem cell in immunotherapy--review].
    Liao LM; Han Q; Zhao CH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):158-63. PubMed ID: 15748459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation.
    Casiraghi F; Noris M; Remuzzi G
    Curr Opin Organ Transplant; 2010 Dec; 15(6):731-7. PubMed ID: 20881495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory properties of human placental mesenchymal stem/stromal cells.
    Abumaree MH; Abomaray FM; Alshabibi MA; AlAskar AS; Kalionis B
    Placenta; 2017 Nov; 59():87-95. PubMed ID: 28411943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.